GLUTATHIONE: 149 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Route: CUTANEOUS · Manufacturer: Guangzhou Kadiya Biotechnology Co., Ltd. · HUMAN OTC DRUG · FDA Label: Available
First Report: 20120101 · Latest Report: 20250913
What Are the Most Common GLUTATHIONE Side Effects?
All GLUTATHIONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Condition aggravated | 26 | 17.5% | 4 | 7 |
| Dyspnoea | 24 | 16.1% | 0 | 4 |
| Pain | 22 | 14.8% | 0 | 4 |
| Drug ineffective | 20 | 13.4% | 2 | 4 |
| Chest pain | 19 | 12.8% | 0 | 1 |
| Malaise | 19 | 12.8% | 0 | 4 |
| Cough | 17 | 11.4% | 0 | 2 |
| Seizure | 17 | 11.4% | 0 | 0 |
| Stomatitis | 17 | 11.4% | 0 | 2 |
| Eczema | 16 | 10.7% | 0 | 1 |
| Eosinophil count increased | 16 | 10.7% | 0 | 1 |
| Metal poisoning | 16 | 10.7% | 0 | 0 |
| Asthma | 15 | 10.1% | 0 | 0 |
| Dysphonia | 15 | 10.1% | 0 | 0 |
| Eosinophilic pneumonia chronic | 15 | 10.1% | 0 | 0 |
| Lung disorder | 15 | 10.1% | 0 | 0 |
| Lung opacity | 15 | 10.1% | 0 | 0 |
| Obstructive airways disorder | 15 | 10.1% | 0 | 0 |
| Pneumonia bacterial | 15 | 10.1% | 0 | 0 |
| Pulmonary mass | 15 | 10.1% | 0 | 0 |
Who Reports GLUTATHIONE Side Effects? Age & Gender Data
Gender: 58.7% female, 41.3% male. Average age: 43.6 years. Most reports from: CN. View detailed demographics →
Is GLUTATHIONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 4 | 0 | 0 |
| 2013 | 3 | 0 | 2 |
| 2014 | 2 | 0 | 1 |
| 2015 | 5 | 0 | 2 |
| 2016 | 2 | 0 | 1 |
| 2017 | 2 | 0 | 1 |
| 2018 | 4 | 0 | 1 |
| 2019 | 6 | 0 | 5 |
| 2020 | 22 | 1 | 4 |
| 2021 | 8 | 1 | 4 |
| 2022 | 4 | 1 | 2 |
| 2023 | 8 | 0 | 4 |
| 2024 | 10 | 0 | 7 |
| 2025 | 3 | 0 | 1 |
What Is GLUTATHIONE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 48 |
| Prophylaxis | 17 |
| Liver disorder | 6 |
| Triple positive breast cancer | 5 |
GLUTATHIONE vs Alternatives: Which Is Safer?
Official FDA Label for GLUTATHIONE
Official prescribing information from the FDA-approved drug label.
FDA Approved Uses (Indications)
Clean a dry, hair-free area (upper arm, abdomen, or back).
Add
8-10 drops of NAD+ solution to the patch. Apply the patch to skin firmly. Leave on for 4-6 hours, then remove and discard.
Dosage & Administration
DIRECTIONS: Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist, consult your health care professional. Consult a physician for use in children under 12 years of age.
Warnings
Warnings: For external use only. Do not exceed the recom- mended dose. Do not apply to broken, irritated, or sensitive skin. Mild redness or tingling may occur and is considered normal. Discontinue use if irritation or rash develops. Pregnant or nursing mothers, children under 18, or individu- als with known medical conditions should consult a physician before use. KEEP OUT OF REACH OF CHILDREN. DO NOT USE IF SAFETY SEAL IS DAMAGED OR MISSING. STORE IN A COOL, DRY PLACE.
Active Ingredient
NAD+ (Nicotinamide Adenine 250 mg Dinucleotide) Vitamin B12 15,000 mcg Glutathione
Inactive Ingredients
AQUA，PROPYLENE GLYCOL，GLYCERETH-26，GLYCERIN，PENTAERYTHRITYL TETRAETHYLHEXANOATE， CAPRYLIC/CAPRIC TRIGLYCERIDE，TITANIUM DIOXIDE，HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE，COPOLYMER，CETEARYL ALCOHOL，XANTHAN GUM，DMDM HYDANTOIN，AROMA，CETEARYL GLUCOSIDE，SILICA，DISODIUM EDTA，ALUMINA，SORBITAN ISOSTEARATE，POLYSORBATE 60，GLYCERYL ACRYLATE/ACRYLIC ACID，COPOLYMER，PEG-90M，BUTYLENE GLYCOL，1,2-HEXANEDIOL，PVM/MA COPOLYMER，IODOPROPYNYL BUTYLCARBAMATE
Used for facial whitening, moisturizing and blemish removal to maintain even and radiant skin.